Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?

被引：16

作者：

Thomson, KS ^{[1
]}

机构：

[1] Creighton Univ, Sch Med, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2000年 / 45卷 / 06期

关键词：

D O I：

10.1093/jac/45.6.719

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：719 / 723

页数：5

共 23 条

[1]

CHEEK WA, 1993, ACP OBSERVER, V13, P15

[2]

Cherubin C. E., 1992, Infectious Diseases Newsletter, V11, P57, DOI 10.1016/0278-2316(92)90025-9

[3] Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity [J].

Fournier, B ;

Hooper, DC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2109-2112

[4] Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus:: Novel pleiotropic effects an quinolone and coumarin activity [J].

Fournier, B ;

Hooper, DC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :121-128

[5] INAPPROPRIATE USE OF ORAL CIPROFLOXACIN [J].

FRIEDEN, TR ;

MANGI, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (11) :1438-1440

[6] CIPROFLOXACIN-INDUCED, LOW-LEVEL RESISTANCE TO STRUCTURALLY UNRELATED ANTIBIOTICS IN PSEUDOMONAS-AERUGINOSA AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].

FUNGTOMC, J ;

KOLEK, B ;

BONNER, DP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1289-1296

[7]

Hooper David C., 1993, P97

[8]

Kohler T, 1998, QUINOLONES, 2ND EDITION, P117

[9] RESISTANCE OCCURRING AFTER FLUOROQUINOLONE THERAPY OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PERITONITIS [J].

MICHEAHAMZEHPOUR, M ;

AUCKENTHALER, R ;

REGAMEY, P ;

PECHERE, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (11) :1803-1808

[10]

*NAT COMM CLIN LAB, 1999, M7A4 NCCLS

← 1 2 3 →